Cargando…
Persistent SARS-CoV-2 Infection in a Multiple Sclerosis Patient on Ocrelizumab: A Case Report
A 44-year-old female patient with multiple sclerosis (MS) treated with ocrelizumab was hospitalized with SARS-CoV-2 pneumonia three times over the course of five months, eventually expiring. Viral sequencing of samples from her first and last admissions suggests a single persistent SARS-CoV-2 infect...
Autores principales: | Ambadapoodi, Raghava S., Arnold, Forest W., Chariker, Julia H., Glynn, Alex, Lauer, William, Marimuthu, Subathra, Rouchka, Eric C., Smith, Melissa L., Wolf, Leslie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104259/ https://www.ncbi.nlm.nih.gov/pubmed/37066424 http://dx.doi.org/10.21203/rs.3.rs-2768759/v1 |
Ejemplares similares
-
Variant analysis of 1,040 SARS-CoV-2 genomes
por: Rouchka, Eric C., et al.
Publicado: (2020) -
Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis
por: Gibson, Elena G, et al.
Publicado: (2021) -
Ocrelizumab: A Review in Multiple Sclerosis
por: Lamb, Yvette N.
Publicado: (2022) -
Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab
por: Katz, J.D., et al.
Publicado: (2022) -
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
por: Cellerino, Maria, et al.
Publicado: (2021)